tiprankstipranks
Trending News
More News >
Elicera Therapeutics AB (DE:8E8)
FRANKFURT:8E8
Germany Market

Elicera Therapeutics AB (8E8) Cash flow

Compare
0 Followers

Elicera Therapeutics AB Cash Flow

DE:8E8's free cash flow for Q4 2025 was kr-10.08M. For the 2025 fiscal year, DE:8E8's free cash flow was decreased by kr1.91M and operating cash flow was kr-10.08M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
kr -21.55Mkr -23.46Mkr -14.92Mkr -8.57Mkr -14.29M
Investing Cash Flow
kr 1.00Kkr 0.00kr 483.17Kkr 0.00kr -1.00K
Financing Cash Flow
kr 20.00Mkr 20.48Mkr 0.00kr 0.00kr 55.12M
End Cash Position
kr 24.85Mkr 26.40Mkr 29.38Mkr 43.82Mkr 52.39M
Free Cash Flow
kr -21.55Mkr -23.46Mkr -14.92Mkr -8.57Mkr -14.29M
Currency in SEK

Elicera Therapeutics AB Cash Flow